These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35169964)
1. Bioinformatics Analysis and Experimental Study of Exonuclease 1 Gene in Lung Adenocarcinoma. Wang S; Cai W; Li J; An W; Zheng H; Liao M Biochem Genet; 2022 Dec; 60(6):1934-1945. PubMed ID: 35169964 [TBL] [Abstract][Full Text] [Related]
2. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma. Chen A; Ding S; Shen X; Lin X Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321 [TBL] [Abstract][Full Text] [Related]
3. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches. Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S PeerJ; 2023; 11():e16166. PubMed ID: 37790630 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation. Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014 [TBL] [Abstract][Full Text] [Related]
5. High Expression of Deng H; Huang Y; Wang L; Chen M Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Family with Sequence Similarity 83, Member A (FAM83A) Predicts Poor Clinical Outcomes in Lung Adenocarcinoma. Zhang JT; Lin YC; Xiao BF; Yu BT Med Sci Monit; 2019 Jun; 25():4264-4272. PubMed ID: 31175804 [TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma. Chen Q; Chen S; Wang J; Zhao Y; Ye X; Fu Y; Liu Y Aging (Albany NY); 2023 Mar; 15(6):2293-2307. PubMed ID: 36971680 [TBL] [Abstract][Full Text] [Related]
8. High TLX1 Expression Correlates with Poor Prognosis and Immune Infiltrates in Patients with Lung Adenocarcinoma. Zhao L; Zheng H; Chen F; Lu H; Yu Q; Yan X; Chen X; Zhang Q; Bu Q Curr Mol Med; 2024; 24(6):801-812. PubMed ID: 37340746 [TBL] [Abstract][Full Text] [Related]
9. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma. Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869 [TBL] [Abstract][Full Text] [Related]
10. Establishment of a prognostic signature for lung adenocarcinoma by integration of 7 pyroptosis-related genes and cross-validation between the TCGA and GEO cohorts: A comprehensive bioinformatics analysis. Zhang W; Wan S; Qu Z; Ge J; Zhang C; Li C; Jiang Y Medicine (Baltimore); 2022 Jul; 101(29):e29710. PubMed ID: 35866781 [TBL] [Abstract][Full Text] [Related]
11. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451 [TBL] [Abstract][Full Text] [Related]
12. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis. Song Y; Tang W; Li H Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330 [TBL] [Abstract][Full Text] [Related]
13. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma. Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689 [TBL] [Abstract][Full Text] [Related]
14. Nonnegative matrix factorization-based bioinformatics analysis reveals that TPX2 and SELENBP1 are two predictors of the inner sub-consensuses of lung adenocarcinoma. Wang H; Wang X; Xu L; Cao H; Zhang J Cancer Med; 2021 Dec; 10(24):9058-9077. PubMed ID: 34734491 [TBL] [Abstract][Full Text] [Related]
15. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma. Yang X; Wang G; Gu R; Xu X; Zhu G PeerJ; 2020; 8():e10418. PubMed ID: 33304656 [TBL] [Abstract][Full Text] [Related]
16. FAM207BP, a pseudogene-derived lncRNA, facilitates proliferation, migration and invasion of lung adenocarcinoma cells and acts as an immune-related prognostic factor. Yu L; Qiao R; Xu J; Han B; Zhong R Life Sci; 2021 Mar; 268():119022. PubMed ID: 33434533 [TBL] [Abstract][Full Text] [Related]
17. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
18. Identification Six Metabolic Genes as Potential Biomarkers for Lung Adenocarcinoma. Zhang S; Lu Y; Liu Z; Li X; Wang Z; Cai Z J Comput Biol; 2020 Oct; 27(10):1532-1543. PubMed ID: 32298601 [TBL] [Abstract][Full Text] [Related]
19. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation. Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526 [TBL] [Abstract][Full Text] [Related]
20. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma. Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]